We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX All Ords share Healius Ltd (ASX: HLS) has taken a significant tumble on Friday amid the company...
Read ArticleASX small-cap stock Findi Ltd (ASX: FND) is surging on Friday and is now 13% higher following an ann...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At th...
Read ArticlePeninsula Energy Ltd (ASX: PEN) shares are taking a beating on Friday. At the time of writing, the A...
Read ArticleOpthea (ASX:OPT), a clinical-stage biopharmaceutical company based in Melbourne, has announced a boo...
Read ArticleEZZ and LTR are among eight ASX companies elevated to the MISC World Microcap Index Truscreen exce...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleThe Appen Ltd (ASX: APX) share price has been on fire in recent weeks. Since this time last month, t...
Read ArticleAppen Ltd (ASX: APX) shares have been major outperformers in 2024 and are up more than 211% since Ja...
Read ArticleThe S&P/ASX All Ordinaries Index (ASX: XAO) closed down 0.68% to 8,416.60 points on Friday. H...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleASX pharmaceutical shares and other healthcare stocks are off to a positive start on Tuesday. Th...
Read ArticleThe All Ordinaries Index (ASX: XAO) has gained a healthy 3.8% since 29 July, but this top ASX All Or...
Read ArticleWoolworths Group Ltd (ASX: WOW) shares have come under pressure this week after the grocery giant fo...
Read ArticleThe Guzman Y Gomez Ltd (ASX: GYG) share price is being put in the spotlight after one of its major i...
Read ArticleInterest rate cuts have been the talk of the investing town, particularly for those who own ASX divi...
Read ArticleInvestors who own Coles Group Ltd (ASX: COL) shares are in for a treat this Wednesday. Sure, the Col...
Read ArticleOn Tuesday, the S&P/ASX 200 Index (ASX: XJO) had subdued session and dropped into the red. The...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is out of form again on Tuesday. In afternoon trade, the bench...
Read ArticleThe ASX share market is an excellent tool for growing our wealth. It has been a good time to be an i...
Read ArticleAustralians have a number of advantages to help grow their wealth for retirement, such as the capita...
Read ArticleThe ASX200 index is experiencing a decline of approximately half a percent, with Consumer Staples st...
Read ArticleIt was a sobering start to the trading week for the S&am...
Read ArticleIt was a great day to have ASX uranium shares in your portfolio. The uranium industry was the stando...
Read ArticleWith so many shares to choose from on the Australian share market, it can be difficult to decide whi...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a subdued start to the week. In afternoon trade, the...
Read ArticleThe ASX200 is trading down about half a per cent with Consumer Staples stocks the biggest drag on th...
Read ArticleASX 200 shares Strike Energy Ltd (ASX: STX) and Sims Ltd (ASX: SGM) are leading the market today wit...
Read ArticleLotus Resources Ltd (ASX: LOT) shares are among the best performers on the Australian share market o...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has given back its early gains and slipped into the red. At t...
Read ArticleUnfortunately for its shareholders, ALS Ltd (ASX: ALQ) shares are being sold off on Thursday morning...
Read ArticleSo, the US Federal Reserve (their version of our RBA) cut interest rates by 0.5%, overnight. For the...
Read ArticleASX set for shaky start after Powell downplays future rate cuts Wall Street fluctuates post-Fed cut...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a gain. In afternoon trade, t...
Read ArticleGuzman Y Gomez Ltd (ASX: GYG) shares have continued their positive run and reached a new high of $42...
Read ArticleCopper stocks elevated to the S&P/ASX 200 and S&P/ASX 300 including Sandfire Resources and...
Read ArticleThe ASX200 has clawed back earlier losses and closed down 0.32%. The Aussie bourse was driven by...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a decline. At the t...
Read ArticleClinuvel chairman tells restless investors the company is on track despite share price weakness Op...
Read ArticleIt's been a pretty rough start to the trading week for ASX shares so far this Monday. At the time of...
Read ArticleThere's something very unhealthy about the degree to which some of our pollies and journos interact...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is making modest gains near midday, up 0.3% to 7,976 points. Th...
Read ArticleDimerix chief Dr Nina Webster describes the three stages of drug development and the hurdles involv...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleLooking to add a few small-cap ASX healthcare stocks to your portfolio with some outsized growth pot...
Read ArticleASX All Ords stock Bravura Solutions Ltd (ASX: BVS) is climbing on Wednesday after the software comp...
Read ArticleASX All Ords stock Bravura Solutions Ltd (ASX: BVS) is climbing on Wednesday after the software comp...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleBravura Solutions Ltd (ASX: BVS) shares are starting the month with a bang. In morning trade, the AS...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleASX rises on Monday after Wall Street banked a belter on Friday All 11 local sectors higher, InfoT...
Read ArticleIf you have a high tolerance for risk and are looking for big investment returns, then read on. That...
Read ArticleThe Core Lithium Ltd (ASX: CXO) share price is surging higher today. Shares in the All Ordinaries...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is out of form on Tuesday. In afternoon trade, the benchmark i...
Read ArticleIt has not been an easy time to invest in ASX lithium stocks. Unless you were shorting them, lithium...
Read ArticleThe All Ordinaries Index (ASX: XAO) is up 0.8% hitting new all-time highs, and it's getting plenty...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has started the week strongly on Monday. In afternoon trade, t...
Read ArticleThe Nanosonics Ltd (ASX: NAN) share price is having a very strong start to the week. In morning trad...
Read ArticleIt's that time of year again when investors check their leaders and laggards and potentially rotate...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleIt is fair to say that the 2024 financial year was not kind to Core Lithium Ltd (ASX: CXO) shares. D...
Read ArticleDespite the past two days of solid gains, the Core Lithium Ltd (ASX: CXO) share price remains down 3...
Read ArticleOpthea (ASX:OPT) has announced the completion of the institutional component of the recently...
Read ArticleThe ASX200 is down a third of a per cent to close the week. All sectors were in the red, except C...
Read ArticleIt was another disappointing session for the Core Lithium Ltd (ASX: CXO) share price. During Friday'...
Read ArticleASX200 dropped on Friday, extending its weekly loss despite Wall Street’s highs Telix Pharma halted...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is having a subdued finish to the week. In afternoon trade, t...
Read ArticleAs the S&P/ASX 200 Index (ASX: XJO) slips around 0.3% into the red on Friday, one ASX 200 stock...
Read ArticleStockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) pe...
Read ArticleAustralian company Opthea (ASX:OPT) has announced it is seeking to raise approximately $227....
Read ArticleASX down 0.5pc, Energy sector up due mainly to Woodside’s upgrade. CRH to acquire Adbri, ending Adb...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticlePainChek granted patent in Europe PainChek (ASX:PCK) has been granted a patent in 20 European nation...
Read ArticleLast Monday marked Clinical Trials Day, when the world’s healing profession celebrated the work of R...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleCheap ASX shares are capable of paying very high dividend yields because of their cheap valuation....
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleA2 Milk Company Ltd (ASX: A2M) shares are on form and rising nicely on Tuesday. At the time of writi...
Read ArticleMuch to the relief of Aussie investors, the S&P/ASX 200 Index (ASX: XJO) is having a much bette...
Read Article“It’s a privilege to join the Board of Opthea at such a transformative time,” said Sujal Sha...
Read ArticleOpthea look to transform standard of care treatment for wet AMD to improve vision outcomes Two Phas...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleClarity says initial data from Phase 1/2 trial is positive Opthea completes enrolment of all patien...
Read ArticleOpthea (ASX:OPT) has announced that it has completed the enrolment of all patients in the CO...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleOpthea (ASX:OPT) has announced that CEO Dr Megan Baldwin will transition to founder and chie...
Read ArticleBenchmark ASX index closes short by -0.04% Materials sector tries but cannot offset everyone else ...
Read ArticleBroker Rating Changes (PostThursday Last Week) Upgrade AMA GROUP LIMITED ((AMA)) Upgrade to Buy from...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleStockhead’s Top 10 at 11, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX 200 benchmark rises almost 0.6% Tech Sector recovers Wednesday’s losses, after Nasdaq positivit...
Read ArticleMelbourne-headquartered biotech company Opthea (ASX: OPT) has kicked off an $80 million capital rais...
Read ArticleThe private equity giant has signalled its intention to take up an option to invest another $80 mill...
Read ArticleClinical-stage biopharmaceutical company Opthea (ASX:OPT) has announced that it is seeking t...
Read ArticleNeuren’s US FDA approval for trofinetide has seen its share price boosted ~130% in past year Eye...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleRumble Resources’s share price could double on zinc demand Opthea could rise more than 4x after Pha...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleHighlights Imugene has advanced its ongoing Phase 1 MAST study with the first patients receiving...
Read ArticleASX 200 to rise on Tuesday ahead of the US CPI report Talk of extraterrestrial in US skies Manchest...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleJeremy Curnock Cook is the Managing Director and founder of BioScience Managers, a funds management...
Read ArticleThe long and short of 2022 is that it was a frustrating period for the Australian biotech sector but...
Read ArticleLightning Minerals identifies multiple pegmatite intrusion outcrops at Dundas project Galan moves t...
Read ArticleA decline in the stock market doesn’t mean you necessarily have to lose money Retail investors are...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleThe Bendigo and Adelaide Bank Ltd (ASX: BEN) share price has suffered in August. Itâs down by 16%...
Read ArticleThe Beach Energy Ltd (ASX: BPT) share price plummeted 11% on Monday following the release of the co...
Read ArticleBiopharmaceutical company Opthea (OPT) receives binding commitments for a US$90 million (A$127 mill...
Read ArticleThe Opthea Limited (ASX: OPT) share price closed 9.35% lower on Monday after the company announced...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is off to the races so far this Monday in a flying start to th...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At...
Read ArticleWhat, exactly, is a CEOâs job? It seems like a simple question. Maybe you even have a simple answ...
Read ArticleThe Bluescope Steel Ltd (ASX: BSL) share price is higher on Monday after the company impressed inve...
Read ArticleThe juryâs still out on the outlook for the big four ASX banks, but thereâs one alternative ASX...
Read ArticleThis article was originally published on Fool.com. All figures quoted in US dollars unless otherwise...
Read ArticleRecent cap raising suggests biotechs may finally be making a comeback Mesblast annnounced a US$45m...
Read ArticleThe S&P/ASX 200 Materials Index (ASX: XMJ) is lifting 1.65% today, but three ASX mining shares...
Read ArticleOpthea (ASX:OPT) has announced a non-dilutive financing transaction for up to US$170 million...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleASX 200 and small caps rise circa 1% Regional markets jump on strong leads, US inflation data Ragus...
Read ArticleOpthea (OPT) enters into a trading halt ahead of a capital raise There is currently no details on h...
Read ArticleIt’s a big day for ASX-listed Opthea, an eye therapies developer with a near $500 million market cap...
Read ArticleThe Carlyle Group and its newly acquired life sciences arm Abingworth are chasing a four-bagger at A...
Read ArticleWhat are the risks of investing in biotechs? How to value a biotech Top 10 crucial trials coming up...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleShareCafeQueuing at the ATM: ASX small caps discover a handy source of funding ASX-listed small cap...
Read ArticleMay. Let’s start with US markets. Because May in the US started with the Dow making its biggest gain...
Read ArticleRetinal biopharmaceutical company Opthea (OPT) presented its clinical data at the Association for R...
Read ArticleOpthea presents data at a renowned medical conference Osprey slashes workforce and is considering f...
Read ArticleUS stocks plunge in a broad based selloff Block Inc down 10% on NYSE as earnings disappoint ASX t...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleOpthea (ASX:OPT) has announced the appointment of Quinton Oswald and Dr Susan Orr to its boa...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleOpthea (ASX:OPT) has announced data was presented at the Bascom Palmer 19th annual Angiogene...
Read ArticleClinical stage biopharmaceutical company Opthea (ASX:OPT) has received a $6.6 million resea...
Read ArticleThe ASX 200 Health Index (XHJ) is falling by 1.5% at the time of writing, compared to the broader in...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleIn October, the Chinese government released its intellectual proprietary (IP) patents strategy paper...
Read Article27 Oct 2021 - Opthea (ASX:OPT) has been granted a Chinese patent covering its lead compound OPT-302....
Read ArticleWall Street touches record highs All three US stock benchmark indexes rose again overnight, as the D...
Read ArticleOpthea (OPT) opens patient enrolment for its Phase 3 clinical program for the treatment of wet age-...
Read ArticleAs the world emerges from the pandemic, markets are now contending with an energy crisis, a global s...
Read ArticleThe ASX 200 Health Index (XHJ) is up by 1.2% at the time of writing, compared to the broader index w...
Read ArticleWall Street continues recent bull run All three US indices rallied again overnight, with oil prices...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and is tum...
Read ArticleThe ASX 200 health stocks index (XHJ) is falling by 0.55% at the time of writing, compared to the br...
Read ArticleOpthea (ASX:OPT) has announced that enrollment in its pivotal Phase 3 clinical program of OP...
Read ArticleTech stocks drag Wall Street lower A selloff in technology stocks dragged Wall Street sharply lower...
Read ArticleLooking for some small cap shares to add to your watchlist? Then have a look at the ones listed bel...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX200 health stocks index (XHJ) fell by 0.14% this morning, compared to the broader index which...
Read ArticleClinical stage biopharmaceutical company Opthea (ASX:OPT) has announced that recruitment is...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At t...
Read ArticleIn early afternoon trade on Tuesday, the S&P/ASX 200 Index (ASX: XJO) has given back its mornin...
Read ArticleThe Opthea Ltd (ASX: OPT) share price is soaring today, up more than 8% trading at $1.37 at the tim...
Read ArticleImmutep (ASX:IMM) and Opthea (ASX:OPT) both received the blessing of the FDA for their clinical tria...
Read ArticleOpthea (ASX:OPT) has announced that the US FDA has granted Fast Track designation for its OP...
Read ArticleDidi ban and Kaseya ransom Wall Street was closed on Monday due to the extended Independence Day lon...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleIn early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is out of form and trading lower. At...
Read ArticleThe best performer on the All Ordinaries on Thursday has been the Opthea Ltd (ASX: OPT) share price...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleThe federal government’s “patent box” initiative caught the eye of Australia’s biotech sector in Tue...
Read ArticleGoldman Sachs hosted its 4th small/mid-cap healthcare forum this week. This included 13 Australian...
Read ArticleClinical-stage biopharmaceutical company Invex Therapeutics (ASX: IXC) has been granted a meeting wi...
Read ArticleSource: PHICHCHA, Shutterstock Small-cap stocks can be surprising investments as they can offer hig...
Read ArticlePitt Street Research has initiated coverage on Melbourne biotech company Exopharm (ASX:EX1), declari...
Read ArticleSource:Ratanapon Srisuneton, Shutterstock Summary Opthea gets an iPSP waiver from the FDA for i...
Read ArticleIn early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain...
Read ArticleThe Opthea Ltd (ASX: OPT) share price is up 8.39% to $1.55 this morning. The rise comes after recei...
Read ArticleWall Street pulls back as tech stocks retreat All the major US indices fell last night. Dow Jones wa...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleEmerging Australian biotechnology company Opthea (ASX:OPT) has announced that the first pati...
Read ArticleSource: Zolnierek, Shutterstock Summary Opthea Limited announced the commencement of dosing in...
Read ArticleOpthea (ASX:OPT) says it has finalised the protocol study designs and key start-up activitie...
Read ArticleClinical-stage biopharmaceutical company Invex Therapeutics (ASX: IXC) has welcomed seasoned drug de...
Read ArticleMegan Baldwin, a biotech executive well-known as CEO of Opthea (ASX:OPT), has come onboard another A...
Read ArticleInvex Therapeutics (ASX: IXC) is aiming to hit some significant milestones in 2021 in its bid to use...
Read ArticleBiopharmaceutical company Opthea is poised to undertake two phase-3 trials for its treatment to impr...
Read ArticleDuring October the ASX200 outperformed most developed markets peers, with the financial and technolo...
Read ArticleMore than a dozen ASX stocks, mostly in healthcare, are dual-listed in America. Another ASX stock is...
Read ArticleIn late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a st...
Read ArticleAustralian clinical-stage biopharmaceutical company Opthea (ASX:OPT) has launched its initia...
Read ArticleOne side of the Australian share market which I think is a great place to look for investment ideas...
Read ArticleSummary ASX and TSX listed Company Orocobre Limited disclosed the successful completion of its SP...
Read ArticleSummary Opthea Limited disclosed that the Company had filed a registration statement for proposed...
Read Article25 Sep 2020 - Biopharmaceutical company Opthea (ASX:OPT) has revealed plans to list American deposit...
Read ArticleI continue to believe that the healthcare sector is a great place to invest with a long term view....
Read ArticleToday we will look at why we like Opthea Limited (ASX OPT). Opthea Limited is an emerging healthcare...
Read ArticleWith biotechnology in focus in 2020, Race Oncology is attracting investor interest. -2020 booming ti...
Read ArticleThe Opthea Ltd (ASX: OPT) share price bounced up 5% then crashed this morning after the biotech com...
Read ArticleThe Opthea Ltd (ASX: OPT) share price is surging higher today. This follows the release of an updat...
Read ArticleI think that every portfolio should have some exposure to the healthcare industry, including 1 or 2...
Read ArticleLong-term shareholders of emerging ASX healthcare company Opthea Ltd (ASX: OPT) have endured a vola...
Read ArticleLike many companies, junior ASX healthcare company Medical Developments International Limited (ASX:...
Read ArticleThe Opthea Limited (ASX: OPT) share price surged more than 20% during trade today, following the co...
Read ArticleThe S&P/ASX 200 (ASX: XJO) is down over 10% compared to this time a year ago. Individual share...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve bee...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAustralia’s top brokers have been busy adjusting their estimates and recommendations again, leading...
Read ArticleThe journey of each individual medical treatment from idea to market requires the involvement of mul...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 134-odd small ca...
Read ArticleAs a sector, healthcare has provided some of the strongest returns over the past year. The S&P/...
Read ArticleHaving now proven its drug works on two eye diseases, Opthea (ASX:OPT) is looking to future treatmen...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAustralian company Opthea (ASX:OPT) has announced topline results from a trial evaluating it...
Read Article10 months since Opthea’s (ASX:OPT) drug proved itself against wet-AMD, it’s passed another clinical...
Read ArticleHas Opthea’s (ASX:OPT) clinical trial of its drug against Diabetic macular edema (DME) been as succe...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleIf exciting small cap ASX shares like Whispir Ltd (ASX: WSP) are too small for your tastes, then yo...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve bee...
Read ArticleHealthcare is not the favourite child it was at the start of the COVID-19 pandemic, but one index me...
Read ArticleThe ASX is home to a small but vibrant and growing biotechnology sector. There are a number of prov...
Read ArticleThe Australian drugs regulator has told sponsors of 10 products to stop marketing them for macular d...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleLast year was a solid year for many ASX stocks and 2020 was also looking pretty good until COVID-19...
Read ArticleThe Australian share market is home to a large number of mid cap shares. The good thing about this...
Read ArticleSpecial Report: Drug developer Dimerix hasn’t been affected by the March market rout and since April...
Read ArticleAfter performing very strongly in 2019, the All Ordinaries index has given back all its gains and m...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) has come under significant pressure over the last couple of mo...
Read ArticleDue to populations around the world getting older and chronic disease burden increasing, demand for...
Read ArticleOne side of the share market which I think is a great place to look for investment ideas is the mid...
Read ArticleAfter a disappointing 43% decline in March, the Afterpay Ltd (ASX: APT) share price has started the...
Read ArticleAt lunch on Tuesday the S&P/ASX 200 Index (ASX: XJO) has continued its positive run and is char...
Read ArticleIn late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record another strong ga...
Read ArticleClinical stage biopharmaceutical company Opthea (ASX:OPT) says it has completed patient dosi...
Read ArticleThe Opthea Ltd (ASX: OPT) share price could be one of the biggest bargains on the ASX according to...
Read ArticleHere it is – your weekly look at the stocks fund managers are buying (and selling). Trading Places i...
Read ArticleThe ASX healthcare sector continues to be one of the top performers on the ASX in terms of share pr...
Read ArticleAt the turn of the millennium Megan Baldwin, high flying CEO of ophthalmology biotech Opthea (ASX:OP...
Read ArticleLast year the ASX’s biotechs began kicking goals they’d promised years ago, as small caps from eye d...
Read ArticleDue to populations around the world getting older and chronic disease burden increasing, demand for...
Read ArticleIn an industry where CEOs rise and fall on the outcomes of their clinical trials, Megan Baldwin is s...
Read ArticleOne of the areas of the market that I’m most bullish on is the healthcare sector. Thanks to a numbe...
Read ArticleGrowing ASX-listed biotech company Paradigm Biopharmaceuticals Ltd (ASX: PAR) has performed strong...
Read ArticleThe Opthea Ltd (ASX: OPT) share price has already surged over 20% higher in January to $3.60 as at...
Read ArticleIf you’re interested in investing in the mid cap side of the market then you’re in luck. At this si...
Read ArticleEarlier today I looked at how successful small cap investing can be if you can identify a start of...
Read ArticleAustralian clinical-stage biopharmaceutical company Opthea (ASX:OPT) says it has completed p...
Read ArticleOver the last 12 months the Opthea Ltd (ASX: OPT) share price has been one of the best performers o...
Read ArticleIn 2019 the culmination of decades worth of work turned several biotechs and life sciences companies...
Read ArticleOver the last decade the healthcare sector has been a great place to investment your money. During...
Read ArticleIn afternoon trade the S&P/ASX 200 index is pushing notably higher. At the time of writing the...
Read ArticleThe Opthea Ltd (ASX: OPT) share price has been a positive performer on Tuesday morning. At the time...
Read ArticleYou don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the...
Read ArticleIt’s been a good year for healthcare shares in 2019. Led by CSL Limited (ASX: CSL), the S&P/ASX...
Read ArticleOn Christmas Day I picked out 10 top ASX shares that I think could be great options for investors i...
Read ArticleThe year is nearly over, so I think it’s time to look back at some of the shares that could be call...
Read ArticleI think the Australian share market is home to a large number of small cap shares that have the pot...
Read ArticleI think a little exposure to the small side of the market can be a good thing for a portfolio. This...
Read ArticleThe Opthea Ltd (ASX: OPT) share price has been one of the best performers on the All Ordinaries in...
Read ArticleThe BWX Ltd (ASX: BWX) share price is pushing higher again on Tuesday. In afternoon trade the perso...
Read ArticleParadigm Biopharmaceuticals Ltd (ASX: PAR) shares are up from 99 cents on New Year’s day 2019 to $3...
Read ArticleI think the ASX is home to a good number of small cap shares that have the potential to grow notabl...
Read ArticleOpthea Limited (ASX: OPT) has completed the private placement announced recently on 2 December 2019....
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleThe process of drug development is launching a new pharmaceutical compound to the market after the l...
Read ArticleAustralian biotechnology company Opthea (ASX:OPT) has announced it has received commitments...
Read ArticleIn afternoon trade the S&P/ASX 200 index is on course to start the week on a high. At the time...
Read ArticleOpthea Limited (ASX: OPT) has received commitments from sophisticated and institutional investors in...
Read ArticleThe Opthea Ltd (ASX: OPT) share price is on the move on Monday after announcing an institutional pl...
Read Article02 Dec 2019 - Biopharmaceutical company Opthea (ASX:OPT) today announced that the company has receiv...
Read ArticleThe participants in the health care industry are always in the process of developing innovative trea...
Read ArticleAustralia’s health care industry is one of the fastest growing industries in the country that is mak...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleIn recent years, Australia’s health care industry has remarkably grown in terms of size and reputati...
Read ArticleThe Next Science Ltd (ASX: NXS) share price has slipped 5% to $2.52 today but investors shouldn’t b...
Read ArticleThe healthcare sector can be viewed with high scepticism as it’s difficult to invest without being...
Read ArticleThe Novita Healthcare Ltd (ASX: NHL) share price is now up around 4.5x or 350% since last week. Tha...
Read ArticleThe Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price has gone gangbusters in 2019 as wild inv...
Read ArticleBotanix Pharmaceuticals’ (ASX:BOT) shares have halved after its anti-acne drug failed its clinical t...
Read ArticleWhat are Small-Cap Stocks? Small-cap stocks are the stocks, which have smaller market capitalisation...
Read ArticleIt looks set to be a disappointing end to the week for the S&P/ASX 200 index. In afternoon trad...
Read ArticleThe market may have dropped lower today, but that hasn’t stopped the Opthea Ltd (ASX: OPT) share pr...
Read ArticleIt’s paramount to hold equities that can capture alpha. By making bets on growth companies, this gi...
Read ArticleStrong gains among selected life science shares is fuelling optimism the sector may have further to...
Read ArticleWith the prospect of a global recession heightening, it’s important to have stocks in your portfoli...
Read ArticleThis year has been a positive one for ASX small caps. According to Bloomberg, the average small cap...
Read ArticleAustralian biopharmaceutical company Opthea (ASX:OPT) has announced the presentation of addi...
Read ArticleOne of the best performers on the All Ordinaries index this year has been the Opthea Ltd (ASX: OPT)...
Read ArticleWhile these last few weeks have been filled with investor uncertainty, there have been clear outper...
Read ArticleThe FDA’s decision on Clinvel Pharmaceuticals’ (ASX: CUV) SCENESSE treatment for erythropoietic prot...
Read ArticleThe Polynovo Ltd (ASX: PNV) share price is up 7% to $2.43 this lunchtime despite the biotech not rel...
Read ArticleThe Orthocell Ltd (ASX: OCC) share price is up 25% to 50 cents today after the regenerative medicin...
Read ArticleHealth care, being the dynamic sector, keep investors on their toes before injecting their funds. Vi...
Read ArticleAnalysts and CEOs of companies targeting vision loss say there’s market opportunities above US$10 b...
Read ArticleAccording to Opthea CEO and managing director, Dr Megan Baldwin, “This R&D tax incentive...
Read ArticleMesoblast limited (ASX: MSB) shares are locked in a trading halt today with the regenerative medicin...
Read ArticleNow that reporting season is over, with the deadline for audited accounts passing yesterday, Stockhe...
Read ArticleThere’s an old saying — ‘an apple a day keeps the doctor away’. But these days, its biotechs — not a...
Read ArticleThis week’s recap of substantial holder transactions among ASX small caps covers everything from fun...
Read ArticleThe AVITA Medical Ltd (ASX: AVH) share price has been on fire again on Wednesday and has carved out...
Read ArticleA lot of retail share market traders like to pile into whatever’s hot or going up fast in the small...
Read ArticleAmidst global trade concerns and lower interest rate environment, investors are turning their invest...
Read ArticleThe S&P/ASX 200 index is on course to end its positive run with a disappointing decline on Tues...
Read ArticleThe share price of the Australian company developing a new eye therapy has quadrupled in rec...
Read ArticleShort & Caught is Stockhead’s fortnightly recap of which ASX small cap stocks are heavily shorte...
Read ArticleIt’s not every day that a former doctoral student takes their thesis and turns it into a $1 billion...
Read ArticleThe Opthea Ltd (ASX: OPT) share price is up 2.4% to $3.83 today after the eye disease treatment bio...
Read ArticleIn morning trade the Domino’s Pizza Enterprises Ltd (ASX: DMP) share price has defied the market de...
Read ArticleThe Ramsay Health Care Limited (ASX: RHC) share price has been a strong performer in 2019. Since th...
Read ArticleThe S&P/ASX 200 index is on course to start the week on a very disappointing note. In afternoon...
Read ArticleLast month the All Ordinaries index recorded its first monthly decline of the year after trade war...
Read ArticleOn Wednesday the S&P/ASX 200 index has been up and down but is pushing higher in afternoon trad...
Read ArticleThe Opthea Ltd (ASX: OPT) share price has been one of the biggest movers on the All Ordinaries inde...
Read ArticleThe Starpharma Holdings Limited (ASX: SPL) share price has been amongst the best performers on the...
Read ArticleA new month is upon us, so what better time to take a look at your portfolio and see if you can imp...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX small cap health stocks. We last checked in...
Read ArticleOn Stockhead today, investors should fall back in love with junior explorers once tech and cannabis...
Read ArticleComing after trial flops from Factor Therapeutics (ASX:FTT), Innate Immunotherapeutics (now Amplia T...
Read ArticleThe S&P/ASX 200 index is on course to record a decline on Tuesday. In afternoon trade the bench...
Read ArticleThe All Ordinaries index may be up materially this year, but some members of the index have thoroug...
Read ArticleIn afternoon trade the S&P/ASX 200 index is on course to finish a volatile week on a positive n...
Read ArticleOpthea (ASX: OPT) doubled on Wednesday after announcing its anti-AMD treatment (OPT-302) worked; but...
Read ArticleOpthea (ASX:OPT), an Australian clinical-stage biopharmaceutical company developing novel bi...
Read ArticleOn Stockhead today – the final wrap from Diggers and Dealers, the feds are finally on board with leg...
Read ArticleThe Australian share market returned to form on Wednesday following two consecutive days of heavy d...
Read ArticleA one-day gain of 148 per cent has Opthea as comfortably the best-performing small cap health or bio...
Read ArticleThe ASX staged a recovery rally today after a sharp fall yesterday. Here’s some of the top performin...
Read ArticleThe Opthea Ltd (ASX: OPT) share price has rocketed 130% to $2.02 this morning after it reported its...
Read ArticleIn afternoon trade the S&P/ASX 200 index has given back a good portion of its morning gains but...
Read ArticleOpthea (ASX: OPT) shares have more than doubled this morning after announcing its Phase IIb clinical...
Read ArticleBiopharmaceutical company Opthea (ASX: OPT) has taken an affirmative step towards commercialising it...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleThe Althea Group Holdings Ltd (ASX: AGH) share price could be on a high on Wednesday following the...
Read ArticleThe Opthea Ltd (ASX: OPT) share price will return from its trading halt this morning and could surg...
Read ArticleOn Stockhead today – mining lithium from seawater, our monthly dairy stocks update, and why Hot Copp...
Read ArticleOpthea (ASX:OPT) is scheduled to update investors tomorrow on the ongoing Phase 2b trial of...
Read Article30 Jul 2019 - Ophthalmic disease therapies company, Opthea (ASX:OPT) has today announced that the Eu...
Read ArticleOpthea (ASX:OPT) has announced that the timing of the primary analysis from its ongoing Phas...
Read ArticleCompanies and institutions that provide medical assistance and services, manufactures of medical equ...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
